Quantifying trade-offs: quality of life and quality-adjusted survival in a randomised trial of chemotherapy in postmenopausal patients with lymph node-negative breast cancer-Reference-Cited by-同舟云学术

Quantifying trade-offs: quality of life and quality-adjusted survival in a randomised trial of chemotherapy in postmenopausal patients with lymph node-negative breast cancer

Published:2004-11 Issue:11 Volume:91 Page:1893-1901
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Bernhard J, ,Zahrieh D,Coates A S,Gelber R D,Castiglione-Gertsch M,Murray E,Forbes J F,Perey L,Collins J,Snyder R,Rudenstam C-M,Crivellari D,Veronesi A,Thürlimann B,Fey M F,Price K N,Goldhirsch A,Hürny C

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/6602230.pdf

Reference43 articles.

1. Ashby J, O Hanlon M, Buxton MJ (1994) The time trade-off technique: how do the valuations of breast cancer patients compare to those of other groups? Qual Life Res 3: 257–265

2. Bala MV, Wood LL, Zarkin GA, Norton EC, Gafni A, O'Brien BJ (1999) Are health states ‘timeless’? The case of the standard gamble method. J Clin Epidemiol 52: 1047–1053

3. Bernhard J, Hürny C, Coates AS, Peterson HF, Castiglione Gertsch M, Gelber RD, Goldhirsch A, Senn HJ, Rudenstam CM (1997) Quality of life assessment in patients receiving adjuvant therapy for breast cancer: the IBCSG approach. The International Breast Cancer Study Group. Ann Oncol 8: 825–835

4. Bernhard J, Lowy A, Maibach R, Hürny C (2001) Response shift in the perception of health for utility evaluation. An explorative investigation. Eur J Cancer 37: 1729–1735

5. Bernhard J, Thürlimann B, Schmitz SF, Castiglione Gertsch M, Cavalli F, Morant R, Fey MF, Bonnefoi H, Goldhirsch A, Hürny C (1999) Defining clinical benefit in postmenopausal patients with breast cancer under second-line endocrine treatment: does quality of life matter? J Clin Oncol 17: 1672–1679

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Quality-Adjusted Survival in Patients with Recurrence of Breast Cancer Diagnosed by Asymptomatic or Symptomatic Opportunities;The Kurume Medical Journal;2022-12-31

2. Survival Outcome of Combined GnRH Agonist and Tamoxifen Is Comparable to That of Sequential Adriamycin and Cyclophosphamide Chemotherapy Plus Tamoxifen in Premenopausal Patients with Lymph-Node–Negative, Hormone-Responsive, HER2-Negative, T1-T2 Breast Cancer;Cancer Research and Treatment;2016-10-15

3. Q-TWiST analysis of panitumumab plus FOLFOX4 versus FOLFOX4 alone in patients with previously untreated wild-type RAS metastatic colorectal cancer;Current Medical Research and Opinion;2016-01-01

4. References;Quality of Life;2015-12-05

5. Quality-adjusted time without symptoms or toxicity (Q-TWiST): patient-reported outcome or mathematical model? A systematic review in cancer;Psycho-Oncology;2014-06-11